Skip to main content

Table 2 Correlates of currently receiving opioid agonist therapy (OAT) among people who inject drug in Iran in 2014

From: Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran

Variables

 

Crude OR (95% CI)

P value

Adjusted OR (95% CI)

P value

Sex

Male

1

   

Female

2.17 (1.07, 4.37)

0.031

  

Age at interview

>35

1.26 (1.02, 1.55)

0.026

  

≤35

1

   

Marital status

Single (never married)

1

 

1

 

Ever married

1.35 (1.13, 1.61)

0.001

1.40 (1.12, 1.75)

0.004

Income

≤200 USD (6,000,000 Rials)

1

   

>200 USD (6,000,000 Rials)

0.93 (0.75, 1.17)

0.569

  

Education level

High school and above

1

   

Less than high school

1.11 (0.89, 1.38)

0.336

  

History of incarceration (ever)

Yes

1.43 (1.12, 1.84)

0.005

1.56 (1.16, 2.09)

0.003

No

1

 

1

 

Substance use type in the past month**

Only opioids

1

 

1

 

Only non-opioids

0.55 (0.33, 0.92)

0.025

0.43 (0.26, 0.71)

0.001

Opioids and non-opioids

0.76 (0.57, 0.92)

0.072

0.66 (0.51, 0.86)

0.001

Self-perceived risk of HIV

Yes

1.13 (0.92, 1.40)

0.223

  

No

1

   

HIV status

Negative

1

 

1

 

Positive

1.72 (1.15, 2.56)

0.009

1.63 (1.08, 2.50)

0.022

Source of recruitment

Outreach

1

   

Facility-based

0.89 (0.67, 1.19)

0.458

  
  1. **Type of substance: non-opioids = Shishe, hashish/grass/cannabis, marijuana, ecstasy, cocaine, and methamphetamine/crystal; opioids = opium, opium sap, opium syrup, heroin, norchizak, tamchizak, buprenorphine, methadone, and crack